To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter describes the normal maturation pattern of plasmacytoid dendritic cells (pDCs), as well as the dynamic antigenic changes during pDC differentiation. Common markers used to define the pDC lineage are included, with their advantages and limitations discussed. Key immunophenotypic features associated with neoplastic pDC proliferations (blastic plasmacytoid dendritic cell neoplasm, myeloid neoplasms with plasmacytoid dendritic cell differentiation, and mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm) are covered. Minimal residual disease evaluation of pDC neoplasms is also discussed. Finally, the differential diagnosis associated with pDC proliferations is addressed.
Acute undifferentiated leukemia (AUL) is part of the group of acute leukemias of ambiguous lineage (ALAL). It is characterized by the expression of immature hematopoietic cell markers but lacks the expression of markers that allow assignment to myeloid or lymphoid lineage. This chapter discusses the immunophenotype and molecular features of AUL and highlights the immunophenotypic features that can help in the differential diagnosis from other entities, including AML with minimal differentiation, AML with megakaryocytic or erythroid differentiation, T-lymphoblastic leukemia, blastic plasmacytoid dendritic cell neoplasm, and rarely, non-hematopoietic neoplasms.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.